BTIG cuts ServiceNow stock price target on guidance concerns

ServiceNow’s first-quarter results were mixed: cRPO grew 20% year over year in constant currency, but BTIG cut its price target to $150 from $185 and estimated the firm effectively reduced fiscal 2026 organic subscription revenue guidance by about $21 million. The company also faces margin pressure from the Armis integration and slower on-premise deal closures in the Middle East, even as AI ACV is now expected to exceed $1.5 billion this year. Multiple brokerages lowered targets, reflecting cautious sentiment around guidance and execution.

Analysis

NOW is in the classic post-beat de-rating phase where the market is punishing the quality of growth, not the existence of growth. The key issue is not the current quarter but the slope of forward bookings once M&A noise and delayed government/regulated deals roll off; if the integration drag is real, the next 2-3 quarters can look mechanically slower even if underlying demand is intact. That makes the stock vulnerable to further multiple compression until management proves that AI monetization is additive rather than just a rebranding of the existing suite.

The bigger second-order effect is competitive: a platform vendor absorbing AI, data, security, and governance can become more defensible, but only if buyers believe the bundle lowers total cost of ownership. If not, the integration story hands ammunition to best-of-breed rivals in workflow, security, and data infrastructure that can argue for faster deployment and cleaner ROI. In that scenario, the “AI ACV” headline may be celebrated in the street while procurement teams still delay platform-wide commitments, creating a mismatch between narrative and conversion.

The market appears to be pricing in a growth reset already, but not yet fully discounting a year of estimate cuts if Analyst Day fails to reaccelerate organic subscription guidance. The near-term catalyst window is 1-3 weeks into the event and then 1-2 quarters afterward, when investors can verify whether the M&A and delayed-deal headwinds were transitory or structural. A contrarian bull case is that the selloff has over-penalized a business with durable margin power; if management shows even modest reacceleration, the stock can rerate sharply because expectations are now low enough that a small positive surprise matters.

Key Decisions for Investors

• Initiate a tactical long NOW call spread into Analyst Day (May 4) with 4-8 week tenor, targeting a re-rating if management restores confidence in organic subscription growth; keep size modest because post-event implied vol is likely elevated.
• If already long NOW, hedge with a 1-2 month put spread against a downside miss on guidance clarity; the stock can easily trade another 10-15% lower if organic growth assumptions are revised again.
• Prefer a relative-value trade: long SNPS or CRM vs short NOW over the next 1-2 quarters if you want exposure to enterprise software with less near-term integration drag and less dependence on a single catalyst.
• Do not chase the dip aggressively until the company proves that AI ACV converts into incremental net new bookings; wait for either a stabilization in cRPO trend or a post-Analyst Day inflection before adding core exposure.
• For contrarian accounts, accumulate NOW only on a failed breakdown after Analyst Day, since the current setup offers asymmetric upside if the market has overdiscounted the M&A and deal-delay headwinds.